Christopher Bhatt
PhD
Senior Scientist
👥Biography 个人简介
Christopher Bhatt is a cancer epigenomics researcher at Memorial Sloan Kettering focusing on BET bromodomain inhibitors and their mechanisms of action in MYC-driven cancers. His research investigated how BRD4 and other BET proteins regulate super-enhancers that drive oncogene expression, particularly MYC amplification in multiple myeloma and lymphoma. He contributed to elucidating resistance mechanisms to BET inhibitors and developing combination strategies to overcome them. His work has informed next-generation BET inhibitor development for hematologic malignancies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Christopher Bhatt 的研究动态
Follow Christopher Bhatt's research updates
留下邮箱，当我们发布与 Christopher Bhatt（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment